PatientsVille.com Logo

NEURALGIA and Furosemide

PatientsVille

NEURALGIA Symptoms and Causes

What is shingles?

Shingles is an outbreak of rash or blisters on the skin. It is caused by the varicella-zoster virus - the same virus that causes chickenpox. After you have chickenpox, the virus stays in your body. It may not cause problems for many years. But as you get older, the virus may reappear as shingles.

Is shingles contagious?

Shingles is not contagious. But you can catch chickenpox from someone with shingles. If you've never had chickenpox or the chickenpox vaccine, try to stay away from anyone who has shingles.

If you have shingles, try to stay away from anyone who has not had chickenpox or the chickenpox vaccine, or anyone who might have a weak immune system.

Who is at risk for shingles?

Anyone who has had chickenpox is at risk for getting shingles. But this risk goes up as you get older; shingles is most common in people over age 50.

People with weakened immune systems are at higher risk of getting shingles. This includes those who

  • Have immune system diseases such as HIV/AIDS
  • Have certain cancers
  • Take immunosuppressive drugs after an organ transplant

Your immune system may be weaker when you have an infection or are stressed. This can raise your risk of shingles.

It is rare, but possible, to get shingles more than once.

What are the symptoms of shingles?

Early signs of shingles include burning or shooting pain and tingling or itching. It is usually on one side of the body or face. The pain can be mild to severe.

One to 14 days later, you will get a rash. It consists of blisters that typically scab over in 7 to 10 days. The rash is usually a single stripe around either the left or the right side of the body. In other cases, the rash occurs on one side of the face. In rare cases (usually among people with weakened immune systems), the rash may be more widespread and look similar to a chickenpox rash.

Some people may also have other symptoms:

  • Fever
  • Headache
  • Chills
  • Upset stomach
What are the complications of shingles?

Shingles can cause complications:

  • Postherpetic Neuralgia (PHN) is most common complication of shingles. It causes severe pain in the areas where you had the shingles rash. It usually gets better in a few weeks or months. But some people can have pain from PHN for many years, and it can interfere with daily life.
  • Vision loss can happen if shingles affects your eye. It may be temporary or permanent.
  • Hearing or balance problems are possible if you have shingles within or near your ear. You may also have weakness of the muscles on that side of your face. These problems can be temporary or permanent.

Very rarely, shingles can also lead to pneumonia, brain inflammation (encephalitis), or death.

How is shingles diagnosed?

Usually your health care provider can diagnose shingles by taking your medical history and looking at your rash. In some cases, your provider may scrap off tissue from the rash or swab some fluid from the blisters and send the sample to a lab for testing.

What are the treatments for shingles?

There is no cure for shingles. Antiviral medicines may help to make the attack shorter and less severe. They may also help prevent PHN. The medicines are most effective if you can take them within 3 days after the rash appears. So if you think you might have shingles, contact your health care provider as soon as possible.

Pain relievers may also help with the pain. A cool washcloth, calamine lotion, and oatmeal baths may help relieve some of the itching.

Can shingles be prevented?

There are vaccines to prevent shingles or lessen its effects. The Centers for Disease Control and Prevention recommends that healthy adults 50 years and older get the Shingrix vaccine. You need two doses of the vaccine, given 2 to 6 months apart. Another vaccine, Zostavax, may be used in certain cases.

Check out the latest treatments for NEURALGIA

NEURALGIA treatment research studies

Furosemide clinical trials, surveys and public health registries


Find Drug Side Effect reports



Furosemide Side Effects

Renal Failure Acute (363)
Hypokalaemia (211)
Dyspnoea (208)
Hypotension (178)
Dehydration (168)
Somnolence (152)
Dizziness (145)
Cardiac Failure (139)
Renal Failure (129)
Syncope (122)
Fall (116)
Asthenia (116)
Hyperkalaemia (109)
Fatigue (108)
Hyponatraemia (108)
Oedema Peripheral (103)
Blood Creatinine Increased (93)
Death (92)
Diarrhoea (88)
Confusional State (85)
Nausea (78)
Vomiting (76)
Renal Impairment (74)
Cardiac Arrest (64)
Cardiac Failure Congestive (63)
Condition Aggravated (63)
Pulmonary Oedema (63)
Malaise (63)
Pain (59)
Atrial Fibrillation (58)
Pneumonia (57)
Respiratory Failure (55)
Hypovolaemia (53)
Oedema (50)
Anaemia (49)
Metabolic Alkalosis (44)
Cough (44)
Electrocardiogram Qt Prolonged (42)
Blood Urea Increased (41)
Pyrexia (40)
Weight Decreased (39)
Toxicity To Various Agents (37)
Gait Disturbance (37)
Loss Of Consciousness (35)
Chest Pain (35)
Pemphigoid (35)
Polyuria (35)
Fluid Retention (34)
Rash (34)
Hypertension (34)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

After about 3 yrs of Lasix (20mg) I developed an unknown allergic reaction that caused blistering on my hands and feet. My feet would get 20-30 at a time and my hands would get hundreds at a time. I had to take medication to keep the breakouts minimi

I am taking 40mgs of furosemide daily it has really helped , i went for a drug screen for a job and it came back altered could you please tell me what caused this ?

I feel light headed, and my eyes feel dry as if wind is blowing. My vision has become unusually blurred and I there is a greenish yellowish tinge around my vision when I go outside in the light. When I first woke up this morning, everything I looked

I have the same feeling, definitely you are not strange.

My doctor has me on 80 mg of furosemide twice daily. What might I expect in side effects?

NOTHING RIGHT NOW BUT I DON>=.T N0 RIGHT NOW

So tired - so weak - hate how I feel

<b>Describe Your Bisoprolol Experience Here:&lt;/b Trigeminal neuralgia. , left neurological chest pain Dose 1.25 twice daily</b>

Gleevec aggravating trigeminal neuralgia

Hi I take Oxcarbazepine for trigeminal neuralgia and i am having difficulty concentrating and seeing clearly, does anyone else have the same or similar experience

Hi Joe - if you already have heart failure, DO NOT take Lyrica. Warnings are on the leaflet within the tablet package. My husband increased his dosage (ignoring my warnings) to 750mg/day for severe trigeminal neuralgia, way above the recommended maxi

I am a homeopath.I am treating a patient, who is suffering from trigeminal neuralgia since 2 yrs.Previously he was a victim of repeated attacks of colds &amp; cough, &amp; he was using Actifed oral, half tablet twice/week,for 20 yrs.RCC stopp

I have an AVM. I was born with this, and it was first found in an MRI 13 years ago. While testing for my symptoms of facial pain (Neuralgia They didnt know it at the time) 2-1/2 years ago, I had another MRI. These results were compared to t

I was prescribed Lyrica by my doctor right after my 18th birthday. I was diagnosed with Post Herpetic Neuralgia (after pain from Shingles) when I was seventeen. Lyrica was the most horrible thing I've ever taken. While taking Lyrica, I was taking 18

James, I realised yours is an old posting, but 3 x 300mg a day is WAY over the maximum recommended dosage! My husband has trigeminal neuralgia and was so desperate to relieve the pain he put himself on 750mg a day (maximum is 600mg). As a direct resu

My husband died in Dec 2007 due to a contradiction of taking Lyrica with Effexor XR. He was taking Lyrica for post herpetic neuralgia. His doc decided in Noc '07 to have him take it daily (ie prophlactically), 2 weeks before his death the doc ha

Trigeminal neuralgia and Chantix. hs anyone been diagonoised with since stopping Chantix.

NEURALGIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers
Condition: Healthy Male and Female Volunteers
Interventions: Drug: Furosemide;   Drug: aminohippurate sodium
Outcome Measures: pharmacokinetic parameter of Furosemide (AUC-24);   pharmacodynamic parameter of Furosemide (Sodium excretion in the urine);   pharmacogenetic parameters;   pharmacokinetic of aminohippuric acid;   other pharmacokinetic parameter of Furosemide;   other pharmacodynamic parameter of Furosemide
2 Not yet recruiting The Use of Furosemide in Patients on Dialysis
Condition: End Stage Renal Disease
Interventions: Drug: Withdrawal of Furosemide;   Drug: Furosemide administration
Outcome Measures: 24 hour urine sodium and water excretion;   Interdialytic weight gain
3 Recruiting Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure
Condition: Acute Decompensated Heart Failure
Interventions: Drug: Intravenous Bolus Furosemide and Oral Metolazone;   Drug: Intravenous Continuous Infusion Furosemide
Outcome Measures: Daily net fluid output;   Patient Global Assessment Scale;   Daily urine output (mL urine out per mg Furosemide received);   Need for additional or alternative diuretic (crossover) or IV vasoactive therapy (study failure);   Death, rehospitalization, and unscheduled visit for HF to an emergency department or outpatient clinic;   Critically low potassium (< 3.5 mmol/L) and magnesium (< 1.6 mg/dL) concentrations;   Change in blood urea nitrogen or creatinine;   Number of hypotensive episodes defined as systolic blood pressure below 85 mmHg or greater than 10 mmHg below baseline (whichever is greater);   Total number of times antihypertensive doses are held due to low blood pressure
4 Unknown  Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
Condition: Acute Heart Failure
Interventions: Drug: Furosemide;   Drug: low-dose dopamine + low-dose Furosemide
Outcome Measures: 1-year mortality or rehospitalization (all-cause, cardiovascular, non-cardiovascular, and due to worsening heart failure).;   60-day mortality or rehospitalization (all-cause, cardiovascular, non-cardiovascular, and due to worsening heart failure).
5 Unknown  The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients
Condition: Intra-Abdominal Hypertension
Intervention: Drug: Furosemide
Outcome Measures: intra-abdominal pressure;   serum creatinine;   need for renal replacement therapy;   ICU mortality;   acid-base status;   hospital and 28d mortality;   duration of mechanical ventilation;   ICU length of stay;   vasopressor dose;   fluid balance;   SOFA score
6 Not yet recruiting Inhaled Furosemide & Dyspnea
Condition: Dyspnea
Interventions: Other: CWS;   Drug: Furosemide;   Drug: Placebo
Outcome Measure: Sensory intensity (Borg 0-10 scale) ratings of dyspnea at isotime
7 Recruiting Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Condition: Acute Kidney Injury
Interventions: Drug: Furosemide;   Procedure: Peritoneal Dialysis
Outcome Measures: Fluid Balance;   Respiratory Support Administered;   NGAL Concentration;   Duration of cardiac ICU stay;   Duration of hospital stay;   All cause mortality;   Renal/electrolyte abnormalities;   Doses of Potassium Chloride or Arginine Chloride required;   B-Natriuretic Peptide
8 Recruiting Furosemide in Early Acute Kidney Injury
Condition: Acute Renal Failure
Interventions: Drug: Furosemide;   Drug: Normal Saline
Outcome Measures: Worsening AKI;   Fluid balance;   Renal replacement therapy (RRT);   Renal Recovery;   Survival
9 Unknown  Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration
Condition: Obesity-induced Hyperfiltration
Intervention: Drug: Furosemide, acetazolamide
Outcome Measure: change in GFR and RPF
10 Recruiting Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea
Condition: Transient Tachypnoea of the Newborn
Interventions: Drug: Furosemide;   Drug: Saline 0,9%
Outcome Measures: Reduction of the Silverman-Score;   Oxygen supplementation;   A need for secondary intubation and mechanical ventilation;   body weight;   CPAP-time;   blood electrolytes (Na+, K+, Ca++, HCO3-, Cl-);   blood gas (pH, pCO2,pO2)
11 Recruiting Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease
Condition: Fluid Overload
Interventions: Drug: Furosemide;   Drug: ethacrynic acid
Outcome Measures: Mean total urine output production in the first post-operative day;   Mean creatinine and NGAL values
12 Unknown  Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates
Condition: Lung Disease
Interventions: Drug: Furosemide;   Drug: Saline
Outcome Measures: Cardiac chamber volume loading.;   Clinical cardio-respiratory stability (heart rate, blood pressure, respiratory rate, oxygen saturation, and oxygen requirement).;   Myocardial performance, cardiac input and output and pulmonary hemodynamics (echocardiograph exam).;   Changes in electrolyte balance, body weight and urine output.
13 Not yet recruiting Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction
Condition: Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction
Interventions: Drug: Furosemide;   Drug: placebo normal saline
Outcome Measures: Diastolic echocardiographic changes following blood transfusion, with or without Furosemide treatment;   clinical outcome following blood transfusion, with or without Furosemide treatment
14 Unknown  Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis
Conditions: Respiratory Failure;   Volume Overload;   Hypernatremia
Interventions: Drug: Supplemental metolazone diuresis;   Drug: Placebo Comparator: Control-- Furosemide (lasix) only
Outcome Measures: Fluid balance;   Serum sodium;   Hyponatremia;   Time to extubation;   Acute Kidney Injury
15 Recruiting Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function
Conditions: Chronic Kidney Insufficiency;   Hemodialysis Treatment;   Diuresis Preserved
Intervention: Drug: Hydrochlorothiazide and Furosemide
Outcome Measures: To asses the effect of combined hydrochlorothiazide-Furosemide therapy on weight gain between haemodialysis sessions in patients with RRF;   To asses the effect of combined hydrochlorothiazide-Furosemide therapy on dialytic, clinical and analytical variables and use of the antihypertensive treatment
16 Not yet recruiting The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
Condition: Heart Failure
Interventions: Drug: Furosemide;   Drug: Torasemide
Outcome Measures: The influence of therapy on cardiovascular events associated with heart failure (deaths, hospitalisations);   The change of dosing of diuretic due to worsening of condition of patient.;   The change of NYHA (New York Heart Association) class - worsening or improvement
17 Unknown  Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure
Condition: Heart Failure
Interventions: Drug: Conivaptan;   Drug: Furosemide;   Drug: Conivaptan and Furosemide
Outcome Measures: renal hemodynamics renal blood flow and glomerular filtration rate;   measure plasma neurohormone levels
18 Unknown  The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission
Condition: Hearing Status
Intervention:
Outcome Measure:
19 Recruiting Aerosol Inhalation Treatment for Dyspnea
Conditions: Healthy;   Dyspnea
Intervention: Drug: Furosemide
Outcome Measures: Subject rating of Breathing Discomfort (dyspnea);   Multidimensional Dyspnea Profile;   Urine output
20 Not yet recruiting A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)
Conditions: Renal Impairment;   Heart Failure
Interventions: Drug: MK-7145 2 mg;   Drug: MK-7145 8 mg;   Drug: Furosemide;   Drug: Torsemide
Outcome Measures: Change from baseline in first 24hr UNa (Part I);   NT-proBNP values at 24 hours post last dose (Part II);   Fold change from baseline for serum creatinine (Part I);   Area under the concentration-time curve from time zero to 24 hours after dosing (AUC0-24hr) for MK-7145 (Part I);   Maximum plasma concentration (Cmax) for MK-7145 (Part I);   Trough plasma concentration (Ctrough) for MK-7145 (Part I);   Time to Cmax (Tmax) for MK-7145 (Part I);   Apparent terminal half-life (t1/2) for MK-7145 (Part I);   Serum creatinine measured at 24 hours post last dose (Part II);   Area under the concentration-time curve from time zero to 24 hours after dosing (AUC0-24hr) for MK-7145 (Part II);   Maximum plasma concentration (Cmax) for MK-7145 (Part II);   Trough plasma concentration (Ctrough) for MK-7145 (Part II);   Time to Cmax (Tmax) for MK-7145 (Part II);   Apparent terminal half-life (t1/2) for MK-7145 (Part II)